Millipore confirms it's in play after shares rocket on rumors

Shares of Millipore shot up at the beginning of the week on a whiff of rumors that the company is in play. Late yesterday, the tool-maker made it official, announcing that it has hired Goldman Sachs to guide them through a look at strategic alternatives--including a possible sale.

Quoting sources, Reuters reports that Thermo Fisher Scientific has offered to buy the company for $6 billion. Millipore shares shot up 36 percent on Monday.

Millipore makes lab materials used in drug development. And aside from the official confirmation that a sale may be in the works, the company signaled it plans to stay mum unless it has a transaction to report.

"Millipore has not set a definitive timetable for completion of its evaluation and there can be no assurances that the process will result in any transaction," the company says in a release. "The company does not intend to disclose developments regarding this process unless and until the board of directors has approved a specific transaction."

- check out the Millipore press release
- here's the story from Reuters

Suggested Articles

I-MAB's anti-GM-CSF drug works "upstream" in inflammation pathways, potentially blocking several dangerous cytokines in COVID-19, executives…

Antibe's lead drug beat placebo at reducing osteoarthritis pain, boosting its case as an alternative to NSAIDs, commonly used to treat the condition.

The trial marks the start of a new phase of the response to SARS-CoV-2 in which people will receive drugs designed specifically for the virus.